Immune repertoire sequencing reveals an abnormal adaptive immune system in COVID‐19 survivors
Секвенирование иммунного репертуара выявляет аномалии адаптивной иммунной системы у лиц, перенесших COVID-19
2022-11-24
SCID: 54.1/4wh3kwpb
Discuss with AI
SARS-CoV-2 neutralizing antibodiesT-cell receptor/B-cell receptor clonesadaptive immune systemimmune repertoire sequencingsomatic hypermutation
Figures from the paper
Abstract (AI)
Abstract Accumulating evidence suggests that severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) impairs the adaptive immune system during acute infection. Still, it remains largely unclear whether the frequency and functions of T and B cells return to normal after the recovery of Coronavirus Disease 2019 (COVID‐19). Here, we analyzed immune repertoires and SARS‐CoV‐2‐specific neutralization antibodies in a prospective cohort of 40 COVID‐19 survivors with a 6‐month follow‐up after hospital discharge. Immune repertoire sequencing revealed abnormal T‐ and B‐cell expression and function with large T cell receptor/B cell receptor clones, decreased diversity, abnormal class‐switch recombination, and somatic hypermutation. A decreased number of B cells but an increased proportion of CD19 + CD138 + B cells were found in COVID‐19 survivors. The proportion of CD4 + T cells, especially circulating follicular helper T (cTfh) cells, was increased, whereas the frequency of CD3 + CD4 − T cells was decreased. SARS‐CoV‐2‐specific neutralization IgG and IgM antibodies were identified in all survivors, especially those recorded with severe COVID‐19 who showed a higher inhibition rate of neutralization antibodies. All severe cases complained of more than one COVID‐19 sequelae after 6 months of recovery. Overall, our findings indicate that SARS‐CoV‐2‐specific antibodies remain detectable even after 6 months of recovery. Because of their abnormal adaptive immune system with a low number of CD3 + CD4 − T cells and high susceptibility to infections, COVID‐19 patients might need more time and medical care to fully recover from immune abnormalities and tissue damage.
Key Findings
1
A prospective six-month follow-up of 40 COVID-19 survivors revealed persistent abnormalities in adaptive immune repertoires after hospital discharge.
2
All participants with severe COVID-19 reported multiple sequelae after six months, suggesting prolonged immune abnormalities and delayed recovery requiring continued medical care.
3
SARS-CoV-2-specific neutralizing IgG and IgM antibodies remained detectable in every survivor six months after recovery, with higher inhibition rates among severe cases.
4
Survivors had fewer B cells but a higher proportion of CD19+CD138+ B cells, increased CD4+ and circulating follicular helper T cells, and fewer CD3+CD4− T cells.
5
T- and B-cell receptor repertoires showed expanded clones, reduced diversity, abnormal class-switch recombination, and altered somatic hypermutation.
Research Object
The adaptive immune system of COVID-19 survivors during the 6 months after hospital discharge
Research Subject
Post-recovery abnormalities in T- and B-cell immune repertoires, cell composition and function, including persistent SARS-CoV-2-specific antibody responses
Publication Details
Publication Date
2022-11-24
Journal
Publisher
ISSN
Cited by
20
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest